[Federal Register Volume 83, Number 48 (Monday, March 12, 2018)]
[Notices]
[Page 10751]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-04841]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Medical Technology Enterprise Consortium

    Notice is hereby given that, on January 18, 2018, pursuant to 
Section 6(a) of the National Cooperative Research and Production Act of 
1993, 15 U.S.C. 4301 et seq. (``the Act''), Medical Technology 
Enterprise Consortium (``MTEC'') has filed written notifications 
simultaneously with the Attorney General and the Federal Trade 
Commission disclosing changes in its membership. The notifications were 
filed for the purpose of extending the Act's provisions limiting the 
recovery of antitrust plaintiffs to actual damages under specified 
circumstances. Specifically, Bramante Bioscience, Elmira Heights, NY; 
California Institute of Biomedical Research (Calibr), La Jolla, CA; 
CIYIS, LLC, Atlanta, GA; Combat Medical Systems, Harrisburg, NC; 
Cortical Metrics, LLC, Carrboro, NC; Duke University, Durham, NC; 
Friedman Research Corporation, Austin, TX; General Dynamics Information 
Technology, Inc., Fairfax, VA; Indiana Biosciences Research Institute, 
Indianapolis, IN; Iowa State University, Ames, IA; Ischemix, Inc., 
North Grafton, MA; Israel Innovation Authority, Airport City, ISRAEL; 
Michigan State University, East Lansing, MI; NeuroRx, Inc., Wilmington, 
DE; Prytime Medical Devices, Inc., Boerne, TX; Rutgers, The State 
University of New Jersey, New Brunswick, NJ; Sheltagen Medical Ltd, 
Atlit, ISRAEL; Studio Kinection, Inc. dba ``Kinection'', Napa, CA; 
TearSolutions, Inc., Charlottesville, VA; The Johns Hopkins University 
Applied Physics Laboratory, LLC, Laurel, MD; The Regents of the 
University of Michigan, Ann Arbor, MI; The University of Alabama at 
Birmingham, Birmingham, AL; The University of Texas at San Antonio, San 
Antonio, TX; The Washington University, St. Louis, MO; TheraNova, LLC, 
San Francisco, CA; Thought Leadership and Innovation Foundation (TLI 
Foundation), McLean, VA; Tympanogen, Inc., Williamsburg, VA; United 
Solutions, LLC, Rockville, MD; Virginia Polytechnic Institute and State 
University, Blacksburg, VA; William Marsh Rice University, Houston, TX; 
and Williams-Jones Consulting, Greenville, SC; have been added as 
parties to this venture.
    Also, CUBRC, Inc., Buffalo, NY; GeoVax, Inc., Smyrna, GA; KIYATEC, 
Inc., Greenville, SC; Manzanita Pharmaceuticals, Inc., Woodside, CA; 
Spherium Biomed SL, Barcelona, SPAIN, and Weinberg Medical Physics LLC, 
North Bethesda, MD; have withdrawn as parties to this venture.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and MTEC intends to file additional 
written notifications disclosing all changes in membership.
    On May 9, 2014, MTEC filed its original notification pursuant to 
Section 6(a) of the Act. The Department of Justice published a notice 
in the Federal Register pursuant to Section 6(b) of the Act on June 9, 
2014 (79 FR 32999).
    The last notification was filed with the Department on October 6, 
2017. A notice was published in the Federal Register pursuant to 
Section 6(b) of the Act on November 6, 2017 (82 FR 51433).

Patricia A. Brink,
Director of Civil Enforcement, Antitrust Division.
[FR Doc. 2018-04841 Filed 3-9-18; 8:45 am]
 BILLING CODE 4410-11-P